ALKEM symptoms a license agreement with Harvard University

ALKEM symptoms a license agreement with Harvard University

by admin- Friday, February 11th, 2022 03:56:06 PM

Alkem Laboratories and Harvard University’s Office of Technology Department (OTD) have signed a license agreement for the development and commercialization
of a novel generation for powerful remedy of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and different accidents caused by vascular sickness.

News Updates